Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

61.23

+0.17 (0.28%)

as of Aug 13, 2026, 8:00:00 pm Market Open.

1631 watching

Investor Insights

Aug 13, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC-T) has shown resilience and growth, particularly in Asia and wealth management, despite recent challenges such as a new tax on its products in Mainland China. The stock appears to be experiencing a phase of high expectations, as evidenced by its notable ranking among Canadian equities. While some experts express caution due to valuations approaching overbought territory, they also recognize MFC's solid fundamentals, including a healthy dividend yield and strong asset management. However, the stock has prompted mixed sentiments regarding its potential for further gains amidst a dynamic financial landscape, with some analysts suggesting it may be time to accumulate shares during a market pullback. Overall, the stock's performance is closely watched, with a general understanding that lower interest rates and strategic positioning may lead to a continued upward trajectory.

Consensus

Cautious

Valuation

Fair Value

Similar

SLF

DON'T BUY

All of the insurance companies are pretty much at the kinds of levels where he doesn't find them attractive to buy. They're at long term highs and he would wait for much better opportunities.

STRONG BUY

Their favourite big financial company. With the addition of John Hancock, they've become one of the big footprints in North America. Their far eastern operations, especially in Japan and China, make fabulous opportunities for them. Probably the best managed financial institution in Canada.

BUY

Prefers this over Great West Life (GWO-T). Has better prospects.

DON'T BUY

Slightly overpriced. Doesn't agree with the market on the gains they are going to make with John Hancock. Prefers Sun Life (SLF-T) and Great West (GWO-T).

WEAK BUY

Looking at this one quite closely. The John Hancock acquisition has really vaulted it into a major North American player. Also likes its global exposure. Handled the Portis situation very well.

BUY

Prefers this company over Sun Life (SLF-T). Likes their global outlook. They have the top management in the industry in North America. John Hancock acquisition was a good one at a good price. Outlook for the life insurance industry is positive.

BUY

Great company. A global leader and great management. Rate of return between this and Sun Life (SLF-T) are quite similar and likes them both.

WEAK BUY

Interest rates will be going up. This tends to be bad for financials, but they have tools in place to hold problems to a minimum. Life companies will do better than banks. OK for a blue-chip portfolio or to balance a portfolio.

BUY

Has done a really tremendous job world wide and handled the John Hancock acquisition without a stumble.

TOP PICK

John Hancock was a good deal. Getting 5.19% yield. Trading at 15 X earnings. The Asian story is very important.

TOP PICK

Because of the large John Hancock acquisition, the market has perceived some issues with integration, so it has taken it down to below 2 X Book Value, so there's no premium in the stock anymore. At the $55 range or lower, he views it as the better opportunity for growth.

WATCH

There's a rising 200 day moving average. At the same time the MACD is giving a very negative signal. Financials are going to do very well for a short period of time. As long as it doesn't break down through $50 to $53 it gives hope that there will be a break on the upside.

WAIT

A great company. John Hancock acquisition was incredible. A global player in the insurance industry which makes a lot of sense. Great story long term, but short term, too much anticipation on their earnings and market will be disappointed. Would buy at 15% or so lower.

TOP PICK

Could be looking next year at $4.75 in earnings going forward. A terrific long term franchise that can grow internationaly.

BUY

Pull back is an opportunity to buy. Expects they will be buying stock back this year and a pretty big increase in the dividend. Should see growth in the core business. Asia is doing well for them.

Showing 1,951 to 1,965 of 2,284 entries

Most Recent Experts

Stan Wong

Private Wealth Management, ScotiaMcleod

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Chris Blumas

at Raymond James Investment Counsel Ltd.

Shannon Saccocia, CIO, Boston Private

Boston Private

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)